Overview

3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability

Status:
Not yet recruiting
Trial end date:
2022-03-17
Target enrollment:
Participant gender:
Summary
This is a single center, Phase 1, randomized, open-label, single-dose, 3 treatment, 3-period, 6-sequence, crossover study designed to compare the PK of SMP-100 dissolved in water for oral administration with SMP-100 tablets under fasting conditions, and to evaluate the effect of food on the bioavailability of SMP-100 tablets in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Chengdu SciMount Pharmatech Co., Ltd.